CAPTRUST Financial Advisors
VNRX icon

CAPTRUST Financial Advisors’s VolitionRx Ltd VNRX Stock Holding History

CAPTRUST Financial Advisors’s Portfolio VNRX Stock Details VNRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-1,250
Closed -$51K – 4016
2022
Q2 		$51K Hold
1,250
– – ﹤0.01% 2741
2022
Q1 		$75K Buy
1,250
+950
+317% +$53.8K ﹤0.01% 2488
2021
Q4 		$19K Buy
+300
New +$20.5K ﹤0.01% 3327

Other funds holding VNRX

LIM
Lagoda Investment Management New York $162M AUM 49.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank Julius Baer & Co
Bank Julius Baer & Co Zurich, Switzerland $33.2B AUM 25.01% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
CPA
Cowen Prime Advisors New York $290M AUM 57.8% 1-Year Est. Return

CAPTRUST Financial Advisors's VNRX Position: Q3 2022 in Review

CAPTRUST Financial Advisors sold out of VolitionRx Ltd (VNRX) in Q3 2022, closing a stake of 1,250 shares — an estimated $51K sold.

CAPTRUST Financial Advisors first reported a position in VNRX in Q4 2021 and held it in 3 quarters. The position peaked at $75K in Q1 2022. 34 funds tracked by Wall St. Rank hold VNRX as of Q3 2022.

  • CAPTRUST Financial Advisors reported no remaining VolitionRx Ltd position as of Q3 2022 after selling out during the quarter.
  • CAPTRUST Financial Advisors sold 1,250 VolitionRx Ltd shares in Q3 2022, an estimated $51K.
  • CAPTRUST Financial Advisors first reported a position in VolitionRx Ltd in Q4 2021 and held it in 3 quarters.
  • CAPTRUST Financial Advisors's VolitionRx Ltd position peaked at $75K in Q1 2022.
  • 34 funds tracked by Wall St. Rank held VolitionRx Ltd as of Q3 2022.

Based on CAPTRUST Financial Advisors's 13F filing for Q3 2022, filed 16 Nov 2022.